Ranitidin AL en es it fr

Ranitidin AL Brand names, Ranitidin AL Analogs

Ranitidin AL Brand Names Mixture

  • Tritec (ranitidine bismuth citrate salt)

Ranitidin AL Chemical_Formula


Ranitidin AL RX_link


Ranitidin AL fda sheet

Ranitidin_AL FDA

Ranitidin AL msds (material safety sheet)

Ranitidin_AL MSDS

Ranitidin AL Synthesis Reference

B. J. Price et al., U.S. Pat. 4,128,658 (1978)

Ranitidin AL Molecular Weight

314.405 g/mol

Ranitidin AL Melting Point

69-70 oC

Ranitidin AL H2O Solubility

24.7 mg/mL

Ranitidin AL State


Ranitidin AL LogP


Ranitidin AL Dosage Forms

Capsule; Liquid; Solution; Tablet; Syrup

Ranitidin AL Indication

Used in the treatment of peptic ulcer disease (PUD), dyspepsia, stress ulcer prophylaxis, and gastroesophageal reflux disease (GERD).

Ranitidin AL Pharmacology

Ranitidine is a histamine H2-receptor antagonist similar to cimetidine and famotidine. An H2-receptor antagonist, often shortened to H2 antagonist, is a drug used to block the action of histamine on parietal cells in the stomach, decreasing acid production by these cells. These drugs are used in the treatment of dyspepsia, however their use has waned since the advent of the more effective proton pump inhibitors. Like the H1-antihistamines, the H2 antagonists are inverse agonists rather than true receptor antagonists.

Ranitidin AL Absorption

Approximately 50% bioavailability orally.

Ranitidin AL side effects and Toxicity

LD50=77mg/kg (orally in mice). Symptoms of overdose include muscular tremors, vomiting, and rapid respiration.

Ranitidin AL Patient Information


Phenylketonurics: ZANTAC 25 EFFERdose Tablets contain phenylalanine 2.81 mg per 25 mg of ranitidine. ZANTAC 150 EFFERdose Tablets
contain phenylalanine 16.84 mg per 150 mg of ranitidine. ZANTAC EFFERdose Tablets should not be chewed, swallowed whole, or dissolved
on the tongue.

Ranitidin AL Organisms Affected

Humans and other mammals